The NextGen Precision Health Discovery Series provides learning opportunities for UM System faculty and staff across disciplines, the statewide community and our other partners to learn about the scope of precision health research and identify potential collaborative opportunities. The series consists of monthly lectures geared toward a broad multidisciplinary audience so all can participate and appreciate the spectrum of precision health efforts.
Information about the upcoming talk, including continuing education, is available below.
For questions about this event or any others in the Discovery Series, please reach out to Mary Hindle at email@example.com.
Strengthening NextGen Medical Informatics Highways
NextGen Medical Informatics is deploying wider access to clinical data and engagement methods to conduct prospective clinical trials and observational studies. You too can leverage this infrastructure to support your research program. Learn how we are planning enhanced capabilities for Missouri as we also renew the Greater Plains Collaborative for PCORnet. The speaker is NextGen Director of Medical Informatics, Russ Waitman, Ph.D.
About the Speaker
Russ Waitman, Ph.D. is the NextGen director of medical informatics and also has roles at MU and UMKC. At MU, he is associate dean for informatics, vice chair for informatics and professor in the Department of Health Management and Informatics, and adjunct professor in the Department of Family and Community Medicine. At UMKC, he is director of the Center for Health Insights at the School of Medicine and a professor in the Department of Biomedical and Health Informatic. Since joining the UM System in 2020, he has worked to establish new methods so investigators across the system can access electronic medical records for research purposes. He also serves on the board of the Tiger Institute for Health Innovation, a public-private partnership between the University of Missouri and Cerner Corporation.
From 2010 to 2020, Waitman served as a professor of internal medicine, the director of the Center for Medical Informatics and Enterprise Analytics, and as the associate vice chancellor for Enterprise Analytics at the University of Kansas Medical Center. There, he worked to establish a strategy for clinical and translational research informatics for Frontiers, the Kansas and Kansas City NIH Clinical and Translational Science Award. Before his time at KU, Waitman served as a faculty member with the Department of Biomedical Informatics in the Vanderbilt University School of Medicine where he led their Computerized Provider Order Entry project, “WizOrder,” and its commercialization to McKesson Corp.
Waitman received a bachelor’s degree in electrical engineering from Washington University in St. Louis and a master’s degree and doctorate from Vanderbilt University in Nashville.
Continuing Professional Education Credit
Up to 1.0 contact hour will be awarded to all participants who view the live sessions in their entirety and complete the evaluation form.
University of Missouri Sinclair School of Nursing is approved as a provider of nursing continuing professional development by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Midwest Multistate Division Provider Number MO1022-6
The Office of Continuing Education, School of Medicine, University of Missouri is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Office of Continuing Education, School of Medicine, University of Missouri designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
CONFLICT OF INTEREST: All persons with influence over the content of this program have been asked to disclose relevant financial interests in the last 12 months that might have an impact. John Spertus, MD, is a consultant for Jannsen, Bayer, Myokardia, Merck and Novartis, and receives research support from Abbott Vascular. No other speaker or planning committee member has a relevant financial interest.